(Q43695526)

25 November 2017

CNS demyelination and quadrivalent HPV vaccination (English)

1 reference

25 November 2017

I Sutton

1

1 reference

25 November 2017

R Lahoria

2

1 reference

25 November 2017

Il Tan

3

1 reference

25 November 2017

P Clouston

4

1 reference

25 November 2017

Mh Barnett

5

1 reference

25 November 2017

19 September 2008

1 reference

Multiple Sclerosis Journal

25 November 2017

1 reference

25 November 2017

15

1 reference

25 November 2017

1

1 reference

25 November 2017

116-119

1 reference

A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis

25 November 2017

1 reference

https://api.crossref.org/works/10.1177%2F1352458508096868

Hepatitis B vaccination and the risk of childhood-onset multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508096868

Hepatitis B vaccination and first central nervous system demyelinating events: reanalysis of a case-control study using the self-controlled case series method

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508096868

Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508096868

Clinical viral infections and multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508096868

Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 35-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508096868

21 January 2018

Identifiers

DOI

10.1177/1352458508096868

1 reference

25 November 2017

1 reference